Marked Improvement in Treatment-Intolerant Obsessive-Compulsive Disorder in an Adolescent Using a Glutamatergic Regimen With Dextromethorphan, Piracetam, and Goldenseal Root.

Cureus March 3, 2026 DOI: 10.7759/cureus.104617 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Peer reviewed

Abstract

Marked Improvement in Treatment-Intolerant Obsessive-Compulsive Disorder in an Adolescent Using a Glutamatergic Regimen With Dextromethorphan, Piracetam, and Goldenseal Root.

Differential Improvement in Obsessive Rumination and Fantasy Intrusions Versus Attachment-Related Emotional Dysregulation During Oral Glutamatergic Augmentation in a 16-Year-Old Adolescent. Cureus July 1, 2026
Optimized Oral Glutamatergic Augmentation in Refractory Home-Dominant Contamination Obsessive-Compulsive Disorder With Somatic, Affective, and Motivational Features: A Case Report of Incremental Functional Gains. Cureus June 1, 2026
An Oral Ketamine-Like Approach to Treatment-Resistant Obsessive-Compulsive Disorder—A Review of Mechanism, Clinical Experience, and Future Directions Preprints.org December 22, 2025 1 citation
Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features Cureus March 17, 2026
Dosing Schedules for Dextromethorphan and Piracetam in OCD: A Case Series on Diurnal Symptom Patterns and Split-Dosing Strategies

Study at a glance

Abstract

Related reading